Fundraising Fox
Pulmonx Corp.
NASDAQ: LUNGSan Jose, US · Delaware corporation · 269 employees on LinkedIn · 7 known investors
Find your way into Pulmonx Corp.
Sign up to see every warm intro you have to Pulmonx Corp.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pulmonx Corp. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery. The company operates in the medical device industry, serving pulmonologists and patients with severe emphysema through a minimally invasive lung treatment.
Founders & leadership
Board
Investors · 7
How we know: HealthCap's portfolio page · a partner's Signal profile · board seat on SEC Form D · biospace.com · Not right? Tell us
How we know: Kaiser Permanente Ventures's portfolio page · Not right? Tell us
How we know: Kleiner Perkins's portfolio page · biospace.com · Not right? Tell us
How we know: Latterell Venture Partners's portfolio page · biospace.com · Not right? Tell us
How we know: Montreux Equity Partners's portfolio page · the S-1 prospectus · biospace.com · Not right? Tell us
How we know: the S-1 prospectus · Not right? Tell us
Funding
SEC filings, press & company announcements$201.1M disclosed across 5 rounds · 2012–2026
- $66MSeries dMay 2026Source ↗
▶$65.1MraisedApr 2019 · 18 investors · OtherRule 506(b)
- STAFFAN LINDSTRANDDirector
- LAUREN CRISTINAExecutive Officer
- GLENDON E. FRENCHExecutive Officer, Director
- RICH FERRARIDirector
- MICHAEL MATLYDirector
- STEPHEN SALMONDirector
- DANA G. MEAD, JRDirector
- CHARLES CHONDirector
- OERN STUGEDirector
- RODNEY PERKINS, M.D.Director
- Offering amount
- $65.1M
- Amount sold
- $65.1M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50MraisedApr 2017 · 1 investors · OtherRule 506(b)
- GLENDON E. FRENCHExecutive Officer, Director
- DANA G. MEAD, JRDirector
- STEPHEN SALMONDirector
- RODNEY PERKINS, M.D.Director
- OERN STUGEDirector
- MICHAEL MATLYDirector
- LAUREN CRISTINAExecutive Officer
- STAFFAN LINDSTRANDDirector
- RICH FERRARIDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedApr 2014 · 17 investors · OtherRule 506(b)
- ANNETTE CAMPBELL-WHITEDirector
- MARTIN SCHNEIDERExecutive Officer
- HOWARD PALEFSKYDirector
- STEVE SALMONDirector
- MICHAEL BAKERExecutive Officer
- LAUREN CRISTINAExecutive Officer
- RODNEY PERKINS, M.D.Executive Officer, Director
- STAFFAN LINDSTRANDDirector
- RICH FERRARIDirector
- DANA MEADDirector
- Offering amount
- $12M
- Amount sold
- $10M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedFeb 2012 · 13 investors · OtherRule 506(b)
- RICH FERRARIDirector
- MICHAEL BAKERExecutive Officer, Director
- HOWARD PALEFSKYDirector
- STAFFAN LINDSTRANDDirector
- RODNEY PERKINS, M.D.Director
- DANA MEADDirector
- ANNETTE CAMPBELL-WHITEDirector
- STEVE SALMONDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Jan 2012
- Incorporated
- Corporation, California
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 1
Companies working in the same space as Pulmonx Corp..
In the news
Frequently asked questions
- What does Pulmonx Corp. do?
- Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery. The company operates in the medical device industry, serving pulmonologists and patients with severe emphysema through a minimally invasive lung treatment.
- Who are Pulmonx Corp.'s investors?
- Pulmonx Corp.'s investors include Band of Angels, HealthCap, Kaiser Permanente Ventures, Kleiner Perkins, Latterell Venture Partners, Montreux Equity Partners, Ally Bridge Group.
- How much funding has Pulmonx Corp. raised?
- Pulmonx Corp. has disclosed $201.1M raised across 5 rounds.
- Where is Pulmonx Corp. headquartered?
- Pulmonx Corp. is headquartered in San Jose, US.